Injectable contraceptives
Injectable hormonal contraceptives (1) are slow release, long lasting progesterone preparations administered intramuscularly at intervals from 1 to 6 months. Common preparations include medroxyprogesterone acetate and norethisterone enanthate.
The main disadvantages are due to the progesterone. Many experience some degree of menstrual disturbance; in some, this can be irregular uterine bleeding which may be heavy and prolonged whilst others may experience amenorrhoea.
Injectable contraception however, may be particularly suited:
- following rubella vaccination in the puerperium
- while awaiting for vasectomy to be proven in a partner
- in women with a chaotic lifestyle where taking an oral contraceptive regularly is difficult
Injectable hormonal contraception is 96% to 99% effective for pregnancy prevention (typical to perfect use) (2)
References:
- Progestogen-only Injectable Contraception Clinical Guidance. Faculty of Sexual and Reproductive Healthcare (December 2014, amended 2020)
- Hatcher R. Contraceptive technology. 21st ed. New York: Ardent Media; 2018.
Related pages
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.